Revised Intimation (Including Resignation Letter) Resignation of Non Executive Independent Director under Regulation 30 of the SEBI(LODR) Regulation, 2015
Announcement under Regulation 30 (LODR)-Resignation of Director
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Intimation Regarding Reconstitution Of Committees Of The Board Of Directors.
- Announcement under Regulation 30 (LODR)-Change in Management
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Standalone Unaudited Financial Results For The 1St Quarter Ended 30Th June 2025
- Board Meeting Outcome for Outcome Of Board Meeting
Later from Welcure Drugs and Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Aug 08 2025
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR), 2015 - Proposal For Stock Split And Bonus Issue
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Aug 11 2025
- Clarification / Correction Under Regulation 30 Of SEBI (LODR), 2015 - Intimation Of Board Meeting Dated 11 August 2025.
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals